scorecardresearch
Business Today
Subscribe
Immersives UPSTART Economy Corporate Petrol-Diesel Weather BT Bazaar
BT 100 BT Accenture PwC De-risking the Future BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
News
Markets
Stocks
Balaxi Pharmaceuticals Ltd

Feedback
Balaxi Pharmaceuticals Ltd

Balaxi Pharmaceuticals Ltd (BALAXI) Share Price

  • Sector: Trading (Small Cap)
  • Volume: 1,121
Aug 29, 2023 15:42 IST-
  • NSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹461.80
₹2.95 (0.64%)
₹458.15 Low
Today’s Performance
₹468.1 High
₹438.8 Low
52 Week’s Performance
₹706 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 0.64%
  • 1 Week -2.90%
  • 1 Month -10.05%
  • 3 Months -23.44%
  • 6 Months -14.87%
  • 1 Year -12.55%
  • 3 Years 2.92%
  • 5 Years 72.61%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.52
  • 52-Week Low (₹) 438.80
  • 52-Week High (₹) 706.00
  • Price-to-Book (X)* 2.69
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 13.33
  • Earnings Per Share (₹) 34.42
  • Sector Price Earning (X)* 46.34
  • Market Cap (₹ Cr.)* 469.41
  • * Vaues as of last close price

COMPETITORS

BT TV

Thumb 36:06 Prime Minister's First Interview On G20 Exclusively To Business Today
Thumb 3:03 PM Modi Distributes More Than 51,000 Appointment Letters Under Rozgar Mela
Thumb 2:57 Pakistan Questions India’s Moon Mission
Thumb 4:44 Countdown To G20 Summit: New Delhi’s Remarkable Transformation And Heightened Security
Thumb 6:34 Wadhawan Brothers' Alleged Privileges Amidst Financial Fraud Charges
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Aug 03, 2020 Sell
Balaxi Ventures Ltd ,AMOL ANAND MANTRI
  • Qty 178450
  • Average Price ₹259.05
Apr 30, 2019 Sell
Balaxi Ventures Ltd ,ALAGAPPAN V.
  • Qty 20000
  • Average Price ₹94.83
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Balaxi Pharmaceuticals Ltd share price previously?
Balaxi Pharmaceuticals Ltd share price was up by 0.64% from the previous closing price of ₹458.85.
Who are peers of Balaxi Pharmaceuticals Ltd?
The peers of Balaxi Pharmaceuticals Ltd are MMTC Ltd, Cartrade Tech Ltd, PTC India Ltd, Redington Ltd, PDS Ltd, Rain Industries Ltd, Hindware Home Innovation Ltd, Aegis Logistics Ltd, Landmark Cars Ltd, MSTC Ltd, Optiemus Infracom Ltd, Sirca Paints India Ltd, Adani Enterprises Ltd,
Who is/are the promoter/promoters of Balaxi Pharmaceuticals Ltd?
The promotor/promotors of Balaxi Pharmaceuticals Ltd are Ashish Maheshwari, Minoshi Maheshwari, Kunal M Bhakta, Gandhi Gamji, M. Srinivas Rao, Chinta Shalini, Purnima Singh Kamble.
What has been 52-week high of Balaxi Pharmaceuticals Ltd stocks?
The highest price of Balaxi Pharmaceuticals Ltd stock is ₹706.00 in the last 52-week.
What is the share price of Balaxi Pharmaceuticals Ltd (BALAXI) today on NSE?
As on Aug 29, 2023, Balaxi Pharmaceuticals Ltd (BALAXI)’s share price on NSE is Rs 461.8
What is the market cap of Balaxi Pharmaceuticals Ltd (BALAXI?)
The current market capitalisation of Balaxi Pharmaceuticals Ltd (BALAXI) is 469.41 crores
What is Balaxi Pharmaceuticals Ltd Share symbol?
The symbol of Balaxi Pharmaceuticals Ltd is BALAXI.
What is the PE ratio of Balaxi Pharmaceuticals Ltd (BALAXI)?
The current PE ratio of Balaxi Pharmaceuticals Ltd (BALAXI) is 13.33.
What is the PB ratio of Balaxi Pharmaceuticals Ltd (BALAXI)?
The current PB ratio of Balaxi Pharmaceuticals Ltd (BALAXI) is 2.69.
Today’s High & Low share prices of Balaxi Pharmaceuticals Ltd (BALAXI) on NSE?
Today, the share price of Balaxi Pharmaceuticals Ltd (BALAXI) on NSE touched a high of Rs 468.1 and a low of Rs 458.15
What price did Balaxi Pharmaceuticals Ltd (BALAXI) shares open on the NSE today?
On NSE, the share price of Balaxi Pharmaceuticals Ltd (BALAXI) opened at Rs 467.95
What is the 52-week high of Balaxi Pharmaceuticals Ltd (BALAXI)?
The 52-week high price of Balaxi Pharmaceuticals Ltd (BALAXI) is Rs 706
What is the 52-week low of Balaxi Pharmaceuticals Ltd (BALAXI) ?
The 52-week low price of Balaxi Pharmaceuticals Ltd (BALAXI) is Rs 438.8

ABOUT BALAXI PHARMA

Balaxi Pharmaceuticals Ltd, incorporated in the year 1942, has its registered office in 41/298-D2 2nd Flr Saniya Plaza, Mahakavi Bharatiyar Road, Cochin, Kerala, 682035, 91-484-4032952/6596725. The main industry in which Balaxi Pharmaceuticals Ltd operates is Trading.

Auditor/Auditors for Balaxi Pharmaceuticals Ltd is/are P Murali & Co. In the main management, is chairman and Chinta Shalini is the company secretary for Balaxi Pharmaceuticals Ltd.

  • AM Ashish Maheshwari Managing Director
  • MM Minoshi Maheshwari Executive Director
  • KMB Kunal M Bhakta Independent Director
  • GG Gandhi Gamji Independent Director
  • MSR M. Srinivas Rao Independent Director
  • CS Chinta Shalini Company Sec. & Compli. Officer
  • PSK Purnima Singh Kamble Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.